AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,877,653 | -28.9% | 256,289 | +123.3% | 0.34% | -78.9% |
| Q1 2019 | $5,452,003 | -35.1% | 114,779 | -50.7% | 1.59% | -65.1% |
| Q4 2018 | $8,403,719 | +13.1% | 232,790 | +92.8% | 4.55% | +39.6% |
| Q3 2018 | $7,429,762 | -51.5% | 120,711 | -46.8% | 3.26% | -53.5% |
| Q2 2018 | $15,327,230 | +34.0% | 226,902 | +7.6% | 7.01% | +32.0% |
| Q1 2018 | $11,434,707 | -20.7% | 210,778 | -12.7% | 5.31% | -36.0% |
| Q4 2017 | $14,428,430 | – | 241,480 | – | 8.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |